In vitro oxidised HDL exerts a cytotoxic effect on macrophages

Atherosclerosis

Volumn 125, Issue 1, 1996, Pages 39-46

  Hurtado, Isabel ^a   Fiol, Concepió ^a   Gracia, Vicente ^a   Caldú, Pilar ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Atherosclerosis; Cytotoxicity; Lag phase; Macrophages; Oxidised HDL; Oxidised LDL; Susceptibility

Indexed keywords

ALPHA TOCOPHEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DAMAGE; CYTOTOXICITY; HUMAN; HUMAN CELL; LIPID OXIDATION; MACROPHAGE; PRIORITY JOURNAL;

EID: 0030598932     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05840-6     Document Type: Article

References (36)

1. [1] Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993;98:1-9.
2. [2] Regnström J, Nilsson J, Tornvall P, Landou C. Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in men. Lancet 1992;339:1183-1186.
3. [3] Gebicki JM, Jürgens G, Esterbauer H. Oxidation of low-density lipoprotein in vitro. In: Sies H. (ed). Oxidative Stress: Oxidants and Antioxidants. New York: Academic Press. Inc., 1991;371-379.
4. [4] Witztum JL, Steinberg D. Role of oxidized low density lipoproteins in atherosclerosis. J Clin Invest 1991;88:1785-1792.
5. [5] Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979;76:333-337.
6. [6] Sparrow CP, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 1989;264:2599-2604.
7. [7] Kuzuya M, Naito M, Funaki Ch, Hayashi T, Asai K, Kuzuya F. Lipid peroxide and transition metals are required for toxicity of oxidized low density lipoproteins to cultured endothelial cells. Biochim Biophys Acta 1991;1996:155-161.
8. [8] Hughes H, Mathews B, Lenz ML, Guyton JR. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler Thromb 1994;14:1177-1185.
9. [9] Hessler JR, Robertson AL, Chisolm GM. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979;32:213-229.
10. [10] Hessler JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 1983;3:215-222.
11. [11] Negre-Salvayre A, Lopez M, Levade Th, Pieraggi MT, Dousset N, Douste-Blazy L, Salvayre R. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. II. Uptake and cytotoxicity of ultraviolet-treated LDL on lymphoid cell lines. Biochim Biophys Acta 1990;1045:224-232.
12. [12] Negre-Salvayre A, Pailluos N, Dousset N, Bascoul J, Salvayre R. Wavelength dependence of photoinduced peroxidation and cytotoxicity of human low density lipoproteins. Photochem Photobiol 1992;55:197-204.
13. [13] Aqel NM, Ball RY, Waldmann H, Mitchison MJ. Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. J Pathol 1985;146:197-204.
14. [14] Tall AR. Plasma high density lipoproteins. J Clin Invest 1990;86:379-384.
15. [15] Ardlie Ng, Selley ML, Simons LA. Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis 1989;76:117-124.
16. [16] Slotte JP, Gronberg L. Oxidation of cholesterol in low density and high density lipoproteins by cholesterol oxidase. J Lipid Res 1990;31:2235-2242.
17. [17] Lavy A, Brook GJ, Dankner G, Ben-Amotz A, Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991;40:794-799.
18. [18] Nagano Y, Arai H, Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 1991;88:6457-6461.
19. [19] Bradamante S, Barenghi L, Giudici GA. Free radicals promote modifications in plasma high-density lipoprotein: nuclear magnetic resonance analysis. Free Rad Biol Med 1992;12:193-203.
20. [20] Salmon S, Maziere C, Auclair M, Theron L, Santus R, Maziere JC. Malondialdehyde modification and copper-induced autooxidation of high density lipoprotein decrease cholesterol efflux from human cultured fibroblasts. Biochim Biophys Acta 1992;1125:230-235.
21. [21] Musanti R, Ghiselli G. Interaction of oxidized HDLs with J774-A1 macrophages causes intracellular accumulation of unesterified cholesterol. Arterioscler Thromb 1993;13:1334-1345.
22. [22] La Ville AE, Sola R, Balanya J, Turner PR, Masana L. In vitro oxidised HDL is recognised by the scavenger receptor of macrophages: implications for its protective role in vivo. Atherosclerosis 1994;105:179-189.
23. [23] Douster-Blazy L, Negree-Salvayre A, Lopez M, Salvayre R. The cytotoxicity of oxidized lipoproteins. Bull Acad Natl Med 1989;173:903-910.
24. [24] Alomar Y, Nègre-Salvayre A, Levade Th, Valdiguié P, Salvayre R. Oxidized HDL are much less cytotoxic to lymphoblastoid cells than oxidized LDL. Biochim Biophys Acta 1992;1128:163-166.
25. [25] Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1959;34:1345-1353.
26. [26] Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
27. [27] Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 1989;6:67-75.
28. [28] Kleinveld HA, Hak-Lemmers HLM, Stalenhoef AFH, Demacker PNM. Improved measurement of low density lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low density lipoprotein. Clin Chem 1992;38/10:2066-2072.
29. [29] Yagi K. A simple fluorimetric analysis for lipoperoxides in blood plasma. Biochem Med 1976;15:212-216.
30. [30] Tsen CC. An improved spectrophotometric method for determination of tocopherols using 4,7-diphenyl-1,10-phenanthroline. Anal Chem 1961;33:849-851.
31. 2+-mediated oxidation. FEBS Lett 1992;314(2):199-202.
32. [32] Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992;13:341-390
33. [33] Bowry VW, Stanley KK, Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 1992;89:10316-10320.
34. [34] Janero D. Therapeutical potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. Free Rad Biol Med 1991;11:129-144.
35. [35] de Graff J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991;11:298-306.
36. [36] Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992;93:189-199.